{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T21:21:36Z","timestamp":1774041696897,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["MOE-113-YSFMN-1009-001-P1"],"award-info":[{"award-number":["MOE-113-YSFMN-1009-001-P1"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","physicamedica.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physica Medica"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejmp.2026.105758","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T14:53:06Z","timestamp":1772549586000},"page":"105758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Modelling of dose-escalated proton beam therapy for Locally Advanced Pancreatic Cancer using simulated phantoms"],"prefix":"10.1016","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8398-6925","authenticated-orcid":false,"given":"Melissa Anne","family":"McIntyre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Midson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puthenparampil","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Gorayski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-En","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Bezak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmp.2026.105758_b1","doi-asserted-by":"crossref","unstructured":"Serafini S, Sperti C, Friziero A, Brazzale AR, Buratin A, Ponzoni A, Moletta L. Systematic review and meta-analysis of surgical treatment for isolated local recurrence of pancreatic cancer. Cancers 13(6). http:\/\/dx.doi.org\/10.3390\/cancers13061277.","DOI":"10.3390\/cancers13061277"},{"key":"10.1016\/j.ejmp.2026.105758_b2","series-title":"Australian institute of health and welfare","year":"2023"},{"key":"10.1016\/j.ejmp.2026.105758_b3","doi-asserted-by":"crossref","unstructured":"Dell\u2019Oro M, Short M, Wilson P, Bezak E. Clinical limitations of photon, proton and carbon ion therapy for pancreatic cancer. Cancers 12(1). http:\/\/dx.doi.org\/10.3390\/cancers12010163.","DOI":"10.3390\/cancers12010163"},{"key":"10.1016\/j.ejmp.2026.105758_b4","doi-asserted-by":"crossref","unstructured":"Sadozai H, Acharjee A, Kayani HZ, Gruber T, Gorczynski RM, Burke B. High hypoxia status in pancreatic cancer is associated with multiple hallmarks of an immunosuppressive tumor microenvironment. Front Immunol 15. http:\/\/dx.doi.org\/10.3389\/fimmu.2024.1360629.","DOI":"10.3389\/fimmu.2024.1360629"},{"key":"10.1016\/j.ejmp.2026.105758_b5","doi-asserted-by":"crossref","unstructured":"Amaral JM, Amaral M, Freitas J, et al. Tumor stroma area and other prognostic factors in pancreatic ductal adenocarcinoma patients submitted to surgery. Diagnostics 13(4). http:\/\/dx.doi.org\/10.3390\/diagnostics13040655.","DOI":"10.3390\/diagnostics13040655"},{"issue":"4","key":"10.1016\/j.ejmp.2026.105758_b6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4240\/wjgs.v9.i4.103","article-title":"Feasibility of pancreatectomy following high-dose proton therapy for unresectable pancreatic cancer","volume":"9","author":"Hitchcock","year":"2017","journal-title":"World J Gastrointest Surg"},{"key":"10.1016\/j.ejmp.2026.105758_b7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.radonc.2018.11.002","article-title":"Phase i trial of concurrent stereotactic body radiotherapy and nelfinavir for locally advanced borderline or unresectable pancreatic adenocarcinoma","volume":"132","author":"Lin","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2026.105758_b8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/jrr\/rrw016","article-title":"Hypofractionated ablative radiotherapy for locally advanced pancreatic cancer","volume":"57","author":"Crane","year":"2016","journal-title":"Radiat Res"},{"issue":"5","key":"10.1016\/j.ejmp.2026.105758_b9","article-title":"Proton therapy for unresectable and medically inoperable locally advanced pancreatic cancer: Results from a multi-institutional prospective registry","volume":"8","author":"Eckstein","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ejmp.2026.105758_b10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.radonc.2019.03.012","article-title":"Concurrent chemoradiotherapy using proton beams for unresectable locally advanced pancreatic cancer","volume":"136","author":"Hiroshima","year":"2019","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ejmp.2026.105758_b11","doi-asserted-by":"crossref","DOI":"10.21037\/jgo-21-593","article-title":"Dose-escalated proton therapy with elective nodal irradiation and concomitant chemotherapy for unresectable, borderline resectable or medically inoperable pancreatic cancer: a phase II trial","volume":"13","author":"Rapp","year":"2000","journal-title":"J Gastrointest Oncol"},{"issue":"2","key":"10.1016\/j.ejmp.2026.105758_b12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.radonc.2009.04.015","article-title":"Dose escalation with proton or photon radiation treatment for pancreatic cancer","volume":"92","author":"Bouchard","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2026.105758_b13","doi-asserted-by":"crossref","unstructured":"Sun G, Yang Z, Fang K, et al. Distribution characteristics and clinical significance of infiltrating T cells in the tumor microenvironment of pancreatic cancer. Oncol Lett 25(261). http:\/\/dx.doi.org\/10.3892\/ol.2023.13847.","DOI":"10.3892\/ol.2023.13847"},{"issue":"2","key":"10.1016\/j.ejmp.2026.105758_b14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00000658-199602000-00006","article-title":"Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy","volume":"223","author":"Fortner","year":"1996","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.ejmp.2026.105758_b15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1634\/theoncologist.2018-0266","article-title":"Pancreas cancer-associated weight loss.","volume":"24","author":"Hendifar","year":"2019","journal-title":"Oncologist"},{"issue":"9","key":"10.1016\/j.ejmp.2026.105758_b16","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.3390\/cancers12092578","article-title":"Influence of target location, size, and patient age on normal tissue sparing- proton and photon therapy in paediatric brain tumour patient-specific approach","volume":"12","author":"Dell\u2019Oro","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejmp.2026.105758_b17","doi-asserted-by":"crossref","unstructured":"Oar A, Lee M, Le H, et al. AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer. BMC Cancer 21. http:\/\/dx.doi.org\/10.1186\/s12885-021-08666-y.","DOI":"10.1186\/s12885-021-08666-y"},{"key":"10.1016\/j.ejmp.2026.105758_b18","doi-asserted-by":"crossref","unstructured":"Hill CS, Han-Oh S, Cheng Z, et al. Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: Does inter-and intra-fraction treatment variation warrant adaptive therapy?. Radiat Oncol 16(53). http:\/\/dx.doi.org\/10.1186\/s13014-021-01782-w.","DOI":"10.1186\/s13014-021-01782-w"},{"issue":"3","key":"10.1016\/j.ejmp.2026.105758_b19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijrobp.2022.07.1096","article-title":"Proton beam therapy for pancreas cancer: Ptcog consensus recommendations for simulation","volume":"114","author":"Amos","year":"2022","journal-title":"Treat Plan Treat Deliv, Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2026.105758_b20","doi-asserted-by":"crossref","unstructured":"Webb S, Nahum AE. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol 39(6). http:\/\/dx.doi.org\/10.1088\/0031-9155\/38\/6\/001.","DOI":"10.1088\/0031-9155\/38\/6\/001"},{"key":"10.1016\/j.ejmp.2026.105758_b21","doi-asserted-by":"crossref","unstructured":"Radonic S, Besserer J, Meier V, Bley CR, Schneider U. A Novel Analytical Population Tumor Control Probability Model Includes Cell Density and Volume Variations: Application to Canine Brain Tumor. Int J Radiat Oncol Biol Phys 110(5). http:\/\/dx.doi.org\/10.1016\/j.ijrobp.2021.03.021.","DOI":"10.1016\/j.ijrobp.2021.03.021"},{"key":"10.1016\/j.ejmp.2026.105758_b22","doi-asserted-by":"crossref","unstructured":"Gholami YH, Willowson KP, Bailey DL. Towards personalised dosimetry in patients with liver malignancy treated with 90Y-SIRT using in vivo-driven radiobiological parameters. EJNMMI Phys 9(49). http:\/\/dx.doi.org\/10.1186\/s40658-022-00479-7.","DOI":"10.1186\/s40658-022-00479-7"},{"key":"10.1016\/j.ejmp.2026.105758_b23","doi-asserted-by":"crossref","unstructured":"Schwarz K, Dobiasch S, Nguyen L, Schilling D, Combs SE. Modification of radiosensitivity by Curcumin in human pancreatic cancer cell lines. Sci Rep http:\/\/dx.doi.org\/10.1038\/s41598-020-60765-1.","DOI":"10.1038\/s41598-020-60765-1"},{"key":"10.1016\/j.ejmp.2026.105758_b24","doi-asserted-by":"crossref","unstructured":"El Shafie RA, Habermehl D, Rieken S, et al. In vitro evaluation of photon and raster-scanned carbon ion radiotherapy in combination with gemcitabine in pancreatic cancer cell lines. J Radiat Res http:\/\/dx.doi.org\/10.1093\/jrr\/rrt052.","DOI":"10.1093\/jrr\/rrt052"},{"key":"10.1016\/j.ejmp.2026.105758_b25","doi-asserted-by":"crossref","unstructured":"Waissi W, Am\u00e9 JC, Mura C, No\u00ebl G, Burckel H. Gemcitabine-Based Chemoradiotherapy Enhanced by a PARP Inhibitor in Pancreatic Cancer Cell Lines. Int J Mol Sci http:\/\/dx.doi.org\/10.3390\/ijms22136825.","DOI":"10.3390\/ijms22136825"},{"key":"10.1016\/j.ejmp.2026.105758_b26","doi-asserted-by":"crossref","unstructured":"Bentzen S, Doerr W, Gahbauer R, et al. Bioeffect modeling and equieffective dose concepts in radiation oncology Terminology, quantities and units. Radiother Oncol 105. http:\/\/dx.doi.org\/10.1016\/j.radonc.2012.10.006.","DOI":"10.1016\/j.radonc.2012.10.006"},{"issue":"104","key":"10.1016\/j.ejmp.2026.105758_b27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2307\/3576626","article-title":"Complication probability as assessed from dose-volume histograms","volume":"8","author":"Lyman","year":"1985","journal-title":"Radiat Res"},{"issue":"2","key":"10.1016\/j.ejmp.2026.105758_b28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0360-3016(89)90462-8","article-title":"Optimization of radiation therapy, iv: A dose-volume histogram reduction algorithm","volume":"17","author":"Lyman","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ejmp.2026.105758_b29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0360-3016(03)01031-9","article-title":"Analysis of radiation-induced gastric and duodenal bleeds using the lyman-kutcher-burman model","volume":"57","author":"Pan","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ejmp.2026.105758_b30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0360-3016(91)90172-Z","article-title":"Fitting of normal tissue tolerance data to an analytic function","volume":"21","author":"Burman","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2026.105758_b31","doi-asserted-by":"crossref","unstructured":"Reinartz G, Baehr A, Kittel C, Oertel M, Haverkamp U, Eich HT. Biophysical Analysis of Acute and Late Toxicity of Radiotherapy in Gastric Marginal Zone Lymphoma - Impact of Radiation Dose and Planning Target Volume. Cancers http:\/\/dx.doi.org\/10.3390\/cancers13061390.","DOI":"10.3390\/cancers13061390"},{"key":"10.1016\/j.ejmp.2026.105758_b32","series-title":"Python 3 reference manual","author":"Van Rossum","year":"2009"},{"key":"10.1016\/j.ejmp.2026.105758_b33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","article-title":"SciPy 1.0: Fundamental algorithms for scientific computing in python","volume":"17","author":"Virtanen","year":"2020","journal-title":"Nature Methods"},{"issue":"7825","key":"10.1016\/j.ejmp.2026.105758_b34","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41586-020-2649-2","article-title":"Array programming with numpy","volume":"585","author":"Harris","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejmp.2026.105758_b35","unstructured":"McIntyre MA, Midson J, Wilson P et al. Patient-Specific Modeling of Dose-Escalated Proton Beam Therapy for Locally Advanced Pancreatic Cancer: Efficacy and Toxicity versus Stereotactic Ablative Radiation Therapy (v1.0.0)http:\/\/doi.org\/10.5281\/zenodo.14213096."},{"issue":"8","key":"10.1016\/j.ejmp.2026.105758_b36","doi-asserted-by":"crossref","DOI":"10.1002\/mp.14212","article-title":"Investigating the impact of alpha\/beta and LETd on relative biological effectiveness in scanned proton beams: An in vitro study based on human cell lines.","volume":"47","author":"Mara","year":"2000","journal-title":"Med Phys"},{"issue":"3","key":"10.1016\/j.ejmp.2026.105758_b37","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/1533034616650778","article-title":"Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study","volume":"16","author":"Comito","year":"2017","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ejmp.2026.105758_b38","first-page":"16","article-title":"Comparison of the dose escalation potential for two hypofractionated radiotherapy regimens for locally advanced pancreatic cancer","author":"Bertholet","year":"2000","journal-title":"Clin Transl Radiat"},{"issue":"4","key":"10.1016\/j.ejmp.2026.105758_b39","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ijrobp.2015.12.003","article-title":"Focal radiation therapy dose escalation improves overall survival in locally advanced pancreatic cancer patients receiving induction chemotherapy and consolidative chemoradiation","volume":"94","author":"Krishnan","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ejmp.2026.105758_b40","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.ijrobp.2016.08.049","article-title":"Spot-scanning proton arc (sparc) therapy: The first robust and delivery-efficient spot-scanning proton arc therapy","volume":"96","author":"Ding","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"17","key":"10.1016\/j.ejmp.2026.105758_b41","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15174268","article-title":"A systematic review of LET-guided treatment plan optimisation in proton therapy: Identifying the current state and future needs.","volume":"15","author":"McIntyre","year":"2000","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.ejmp.2026.105758_b42","first-page":"517","article-title":"Pancreatic adenocarcinoma","volume":"115","author":"Vareedayah","year":"2018","journal-title":"Mo Med"},{"issue":"4","key":"10.1016\/j.ejmp.2026.105758_b43","article-title":"Dose escalation for pancreas SBRT: Potential and limitations of using daily online adaptive radiation therapy and an iterative isotoxicity automated planning approach","volume":"8","author":"Rhee","year":"2023","journal-title":"Adv Radiat Oncol"},{"issue":"4","key":"10.1016\/j.ejmp.2026.105758_b44","first-page":"361","article-title":"Measurement of tumor hypoxia in patients with advanced pancreatic cancer based on 18f-fluoroazomyin arabinoside uptake.","volume":"12","author":"Metran-Nascente","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Physica Medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179726000451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179726000451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T19:32:54Z","timestamp":1774035174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1120179726000451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":44,"alternative-id":["S1120179726000451"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmp.2026.105758","relation":{},"ISSN":["1120-1797"],"issn-type":[{"value":"1120-1797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modelling of dose-escalated proton beam therapy for Locally Advanced Pancreatic Cancer using simulated phantoms","name":"articletitle","label":"Article Title"},{"value":"Physica Medica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmp.2026.105758","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd on behalf of Associazione Italiana di Fisica Medica e Sanitaria.","name":"copyright","label":"Copyright"}],"article-number":"105758"}}